NCT06873425

Research on the Improvement of Intestinal and Immune Functions by Probiotics

A Study on the Safety and Effectiveness of Limosilactobacillus Fermentum LF61 in Improving Intestinal and Immune Functions

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Wecare Probiotics Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

Evaluate the effectiveness and safety of Limosilactobacillus fermentum LF61 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.

Conditions

• Intestinal Health

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Probiotic	Dietary supplement: Probiotics. The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).
DIETARY_SUPPLEMENT	Placebo	Dietary supplement: Placebo. The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).

Timeline

• Start date: 2025-03-10
• Primary completion: 2025-09-30
• Completion: 2025-12-30
• First posted: 2025-03-12
• Last updated: 2025-03-12

Locations

1 site across 1 country: China